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Atlas of Liver Biopsies. H. POULSEN an1d
P. CHRISTOFFERSON (1979) Copenlhagen:
Munksgaard. 239 pp. 185 figs. 350.10
Danish Kroner.
This excellent atlas is based on the autlhor's
experience with over 11,000 liver biopsies.
There is a brief chapter on techniques of
obtaining and processing the biopsy. The
main chapter considers the various abnormal
morplhological features that may be encoun-
tered (alterations in lobular architecture,
portal tracts, liver cells, etc.) and their pos-
sible significaiice. A shorter clhapter describes
how these individual features may be com-
bined in the major liver diseases (hepatitis,
cirrhosis, etc.). There are excellent, bibliog-
raplhies, and ani appendix ofstaining methods.
However, the value of this atlas is in its
excellent colour photomicrographs these are
uniforml,y informative, and the standard of
reproduction is very true to life. The diagnosis
of neoplasia is not one of the major problems
for the pathologist dealing with liver biopsies,
and this aspect of liver pathology is only
briefly dealt -with. But, this atlas can con-
fidently be recommended as a practical guide
to histopathology; unfortunately its price is
likely to prove somewhat daunting.
0. G. DODGE
Man, Cancer and Immunity. Ed. A. J.
COChIRAN (1979) London: Acadernic Press.
206 pp. £7.80.
The production of a book dealing solely
with studies in man relating to immunliological
aspects of the tumour-host relationslhip is a
daunting task. The number of studies whicl
are unequivocally consistent, with the concept
that progression to malignant disease is
accompanied by the expression of novel anti-
genic components against which the host is
capable of mounting an effective imnmuno-
logical reaction are indeed few%N. The field
abounds -with controversy, and in spite of a
massive effort it cannot yet, be stated with
any certainty that the basic premnise oftumour
immunity in man is proven. It is against this
background that this book slhould be assessed.
It provides a reviewr of the somewhat super-
ficial exvidence we have to date of an immune
involvement in the control of malignancy,
and is indeed timely as the subject moves
towards a more in-depth analysis with the
less subjective technolgov that is now be-
coming availalle and wvhich has provided
suclh insight, inito the biology of the immune
system.
The author starts logically wvith clinical
observations suchi as histological appearances,
tumour dormtancy and the association of
malignancy wvith immunosuppression and
age, which are suggestive of a host response
before considering the in vivo and ini vitro
assays wN-hich have been applied to the study
of tumour immunogenicity. This latter
section may appear uncritical at times, with
reference t,o the problems of interpretation of,
for example, cytotoxicity assays and the ready
acceptance of sulchl studies in the establish-
ment of the presence and nat,ure of blocking
factors in patients' sera. Much is also made
of the migrationi-inhibition test, reflecting the
author's interest and involvement, though
again this is a technique which has not gained
universal acceptance as applied t,o the cancer
problem. The presence ofactual test data in a
book of this type is novel, and may be con-
fusing to readers unfamiliar w-ith the assays.
It must be said that much of this section has
appeai-ed previously in the book "Immuno-
logical Aspects of Cancer" edited by J. E.
Castro.
The later sections of the book deal wvith
practical applications of studies of immuno-
logy of cancer patients, and the effects of
ti-eatment, on the immune system. In each
chapter it is point,ed out that the reasons for
the apparent differences bet-ween the cancer
patients and control are poorly understood
and by no means uniform so that the sig-
nificance of these differences is unclear. The
goal of tumour immunology in immuno-
diagnosis and serial monit,oring of disease
progression is as yet unattainable, except in
a few wx-ell defined conditions. The final chap-
ter document,s the attempts to use immuno-
therapy in malignant disease.BOOK REVIEWS 325
The author stresses that the results have
been largely disappointing and are awaiting
new active agents and models with which the
most effective use of the agents available
could be established.
This is a book concentrating on human
malignancy written for clinicians, and pro-
vides a readable account of a complicated
field which continues to develop rapidly. It
rightly stresses that our knowledge is in-
complete, and provides a useful introduction
to tumour immunology. A number of texts
on this subject have recently appeared, and
the lack of a thorough consideration of the
animal model and effector mechanisms makes
this one less attractive as a book for general
recommendation.
B. M. VOSE
Controlled Therapeutic Trials in Cancer.
UICC Technical Report Series-Vol 32.
Eds. R. FLAMANT and C. FOHANNO (1978)
Geneva: International Union Against Can-
cer. 684 pp. 28.00 Sw. fr.
This volume is a comprehensive collection,
compiled by the UICC, of all clinical trials
registered with the UICC information office
by June 1977. The plan of data collection is
outlined in the introduction to the book, and
thereafter a series of tables defines the trial
according to the disease site, with further
details on the protocol and of the relevant
investigating unit. One of the major short-
comings in this volume is the lack of cross-
reference by means of an author index but,
none the less, for any group of practising
clinical research oncologists this is an impor-
tant summary of currently registered ongoing
trials in malignant disease. Although it is
unlikely that any individual would want to
possess such a volume, it will be an invaluable
reference for an oncological library.
H. BusH
Comprehensive Immunology. No. 4 Im-
munopathology of Lymphoreticular
Neoplasias. Eds. R. A. GOOD and 8. B.
DAY (1979) New York: Plenum Press.
763 pp. £28.35.
So rapid has been the expansion of our
knowledge of the immunopathology of lym-
phoreticular neoplasia that it seems scarcely
10 years since the discussion of these malig-
nancies was dominated exclusively by mor-
phological considerations and clinical mat-
ters. The combined fields of immunology,
cytochemistry and immunochemistry have
opened new approaches wNhich have quickly
proved applicable to the study oflymphomas.
The cytoidentity of primary neoplastic cells
is nowr more clearly recognized and their
clonal nature has been established. More
subtle immunological perturbations have
also become apparent.
This voluine lives up to the title ofthe series
of which it is the 4th of 5 parts (to date), in
that the degree of coverage approaches
monumental proportions. An initial series of
chapters provides the normal structural and
functional framewNork for the aberrations of
the lymphoid system wrhich follow%. These
include contributions on lymphoid-tissue
development, immunoregulation and ageing
and involution of the immune apparatus.
The high frequency of cancers in patients
with either primary genetically determined or
iatrogenic immunodeficiency is discussed in
excellent chapters by B. Spector and col-
leagues, and I. Penn respectively. In the
former, the results of an international effort
to collect data on cancers in patients with
primary immunodeficiences are presented,
and in the latter there is the encouraging fact
that disseminated cancers arising from malig-
nant cells inadvertently present in trans-
planted organs, can be eradicated on restora-
tion of immune function.
The application of the marker techniques
wNrhich have provided new criteria ofclassifica-
tion and analysis is discussed in 2 lucid
chapters by F. P. Seigal (Cytoidentity of
lymphoreticular neoplasias) and E. C. Frank-
lin and J. Buxbaum (Immunoglobulins in
the normal state and in neoplasias of B cells).
These contributions provide the rationale
for eventual prevention and improved treat-
ment, particularly since the technical ad-
vances therein described now make it possible
in some instances to identify the cell of origin
of the lymphomas.
This volume also contains a number of
presentations which should be useful to the
clinician. S. A. Rosenberg contributes a
chapter on the Treatment of Primary Lym-
phoid Neoplasias, and elsewhere in the book
Hodgkin's Disease receives much attention.
Perhaps of greatest clinical interest, however,
is a chapter (by R. H. Marshak ande.colleagues)